Heparin, Low-Molecular-Weight Concept

subject area of

• 2 Mechanisms of action of low molecular weight heparins and heparinoids  Journal Articles
• 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer  Journal Articles
• 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19  Journal Articles
• 4 Clinical potential of low molecular weight heparins  Journal Articles
• A Comparison of General Anesthesia and Regional Anesthesia as a Risk Factor for Deep Vein Thrombosis Following Hip Surgery: A Critical Review  Journal Articles
• A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee Implantation  Journal Articles
• A Histomorphometric Comparison of the Effects of Heparin and Low-Molecular-Weight Heparin on Cancellous Bone in Rats  Journal Articles
• A Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous Thromboembolism  Journal Articles
• A multicentre controlled pre–post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients  Journal Articles
• A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.  Journal Articles
• A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.  Journal Articles
• A review of the two major regulatory pathways for non-proprietary low-molecular-weight heparins  Journal Articles
• A systematic review of economic analyses of low-molecular-weight heparin for the treatment of venous thromboembolism  Journal Articles
• ABC of antithrombotic therapy: Venous thromboembolism: treatment strategies  Journal Articles
• AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery – TREK: a dose-ranging study  Journal Articles
• Addressing the burden of hospital‐related venous thromboembolism: the role of extended anticoagulant prophylaxis  Journal Articles
• Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness  Journal Articles
• Advances and Contemporary Issues in Prophylaxis for Deep Vein Thrombosis  Journal Articles
• Advances and contemporary issues in prophylaxis for deep vein thrombosis.  Journal Articles
• Advances in the management of venous thromboembolism  Journal Articles
• Advances in the management of venous thromboembolism.  Journal Articles
• Airways Disease Presenting as Restrictive Impairment: Response  Journal Articles
• Alternatives to Low Molecular Weight Heparin for Anticoagulation in Pregnant Women with Mechanical Heart Valves in Middle-Income Countries: A Cohort Study  Journal Articles
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy  Journal Articles
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients  Journal Articles
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy  Journal Articles
• American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer  Journal Articles
• An Approach to Assigning In Vitro Potency to Unfractionated and Low Molecular Weight Heparins Based on the Inhibition of Prothrombin Activation and Catalysis of Thrombin Inhibition  Journal Articles
• An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial  Journal Articles
• An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial  Journal Articles
• An overview of clinical trials of low molecular weight heparin fractions.  Journal Articles
• An overview of clinical trials of low molecular weight heparin fractions.  Journal Articles
• Angina (unstable).  Journal Articles
• Angina (unstable).  Journal Articles
• Angina (unstable).  Journal Articles
• Anticoagulant Effect at the Time of Epidural Catheter Removal in Patients Receiving Twice-daily or Once-daily Low-molecular-weight Heparin and Continuous Epidural Analgesia after Orthopedic Surgery  Journal Articles
• Anticoagulant Mechanisms of Orgaran (Org 10172) and Its Fraction with High Affinity to Antithrombin III (Org 10849)  Journal Articles
• Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography  Journal Articles
• Anticoagulant prophylaxis in special populations with an indwelling epidural catheter or renal insufficiency  Journal Articles
• Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis  Journal Articles
• Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis  Journal Articles
• Anticoagulant therapy in acute brain ischaemia  Journal Articles
• Anticoagulants in acute coronary syndromes  Journal Articles
• Anticoagulation Therapy  Journal Articles
• Anticoagulation Therapy in Children  Journal Articles
• Anticoagulation and Bleeding: A Pooled Analysis of Lung Cancer Trials of the NCIC Clinical Trials Group  Journal Articles
• Anticoagulation for patients discharged from the emergency department with venous thromboembolism.  Journal Articles
• Anticoagulation for patients with cancer and central venous catheters  Journal Articles
• Anticoagulation for people with cancer and central venous catheters  Journal Articles
• Anticoagulation for people with cancer and central venous catheters  Journal Articles
• Anticoagulation for people with cancer and central venous catheters  Journal Articles
• Anticoagulation for perioperative thromboprophylaxis in people with cancer  Journal Articles
• Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer  Journal Articles
• Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer  Journal Articles
• Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer  Journal Articles
• Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer  Journal Articles
• Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer  Journal Articles
• Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters  Journal Articles
• Anticoagulation therapy in patients with prosthetic heart valves.  Journal Articles
• Antithrombin-Independent Anticoagulation by Hypersulfated Low-Molecular-Weight Heparin  Journal Articles
• Antithrombins: Their Potential as Antithrombotic Agents  Journal Articles
• Antithrombotic Therapy for Coronary Artery Disease  Journal Articles
• Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes  Journal Articles
• Antithrombotic Therapy in Children*  Journal Articles
• Antithrombotic Therapy in Coronary Ischaemia: The Expanding Role of Low-Molecular-Weight Heparin  Journal Articles
• Antithrombotic Therapy in Neonates and Children  Journal Articles
• Antithrombotic Therapy in Neonates and Children  Journal Articles
• Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Journal Articles
• Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents  Journal Articles
• Antithrombotic therapy in children with venous thromboembolism  Journal Articles
• Antithrombotic therapy: the expanding role of low molecular weight heparin.  Journal Articles
• Antithrombotics and Anticoagulants in Coronary Syndromes and Stroke  Journal Articles
• Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery  Journal Articles
• Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement  Journal Articles
• Are There Patients With Acute Ischemic Stroke and Atrial Fibrillation That Benefit From Low Molecular Weight Heparin?  Journal Articles
• Aspirin Versus Low-Molecular-Weight Heparin for Ischemic Stroke in Children: An Unanswered Question  Journal Articles
• Assessment of Outpatient Treatment of Deep-Vein Thrombosis With Low-Molecular-Weight Heparin  Journal Articles
• Assessment of a venous thromboembolism prophylaxis shared decision-making intervention (DASH-TOP) using the decisional conflict scale: a mixed-method study  Journal Articles
• Association between perioperative low-molecular-weight heparin vs unfractionated heparin and clinical outcomes in patients with cancer undergoing surgery  Journal Articles
• Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: A multicenter survey  Journal Articles
• Barriers and facilitators to adopting high value practices and de-adopting low value practices in Canadian intensive care units: a multimethod study  Journal Articles
• Benefit of Selective Factor Inhibition  Journal Articles
• Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials  Journal Articles
• Beyond Heparin and Aspirin  Journal Articles
• Beyond Unfractionated Heparin and Warfarin  Journal Articles
• Binding of heparin to plasma proteins and endothelial surfaces is inhibited by covalent linkage to antithrombin  Journal Articles
• Biologic rationale for the therapeutic role of specific antithrombins  Journal Articles
• Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures  Journal Articles
• Bridging Anticoagulation  Journal Articles
• Bridging Anticoagulation in Patients with Atrial Fibrillation  Journal Articles
• Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation  Journal Articles
• Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery  Journal Articles
• Can we differentiate the low-molecular-weight heparins?  Journal Articles
• Can we optimise treatment of thrombosis?  Journal Articles
• Central venous catheters are an important factor in paediatric thrombosis  Journal Articles
• Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management  Journal Articles
• Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: The CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction  Journal Articles
• Changing Paradigms in the Management of Venous Thromboembolism  Journal Articles
• Chills and limb pain following administration of low‐molecular‐weight heparin for treatment of acute venous thromboembolism  Journal Articles
• Choice of low molecular weight heparins  Journal Articles
• Choice of low molecular weight heparins.  Journal Articles
• Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy  Journal Articles
• Clinical Studies with Anticoagulants that Have Changed Clinical Practice  Journal Articles
• Clinical outcomes with unfractionated heparin or low‐molecular‐weight heparin as bridging therapy in patients on long‐term oral anticoagulants: the REGIMEN registry  Journal Articles
• Clinical potential of antithrombotic drugs in coronary syndromes  Journal Articles
• Close Approximation of Two Platelet Factor 4 Tetramers by Charge Neutralization Forms the Antigens Recognized by HIT Antibodies  Journal Articles
• Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - A direct and selective antagonist  Journal Articles
• Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?  Journal Articles
• Comparative effects of heparin and LMW heparin on hemostasis  Conferences
• Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance.  Journal Articles
• Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry)  Journal Articles
• Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis  Conferences
• Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous Thromboembolism  Journal Articles
• Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)  Journal Articles
• Comparison of pain and ecchymosis with low-molecular-weight heparin vs. unfractionated heparin in patients requiring bridging anticoagulation after warfarin interruption: a randomized trial  Journal Articles
• Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism  Journal Articles
• Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis  Conferences
• Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.  Journal Articles
• Comparison of the relative efficacy and safety of low-molecular-weight heparin and unfractionated heparin for the treatment of venous thrombosis.  Journal Articles
• Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism  Journal Articles
• Controversies in Timing of the First Dose of Anticoagulant Prophylaxis Against Venous Thromboembolism After Major Orthopedic Surgery  Journal Articles
• Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.  Journal Articles
• Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism  Journal Articles
• DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines  Journal Articles
• Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed methods pilot study protocol  Journal Articles
• Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed-methods pilot study  Journal Articles
• Decreased Concentrations of Heparinoids Are Required to Inhibit Thrombin Generation in Plasma from Newborns and Children Compared to Plasma from Adults due to Reduced Thrombin Potential  Journal Articles
• Deep vein thrombosis: update on diagnosis and management  Journal Articles
• Delayed‐onset HIT caused by low‐molecular‐weight heparin manifesting during fondaparinux prophylaxis  Journal Articles
• Development of the IRIS-AR strategy: an intervention to improve rates of accrual and retention for the VTE-PRO randomized controlled trial  Journal Articles
• Diagnosis and Anticoagulant Treatment  Journal Articles
• Diagnosis and Treatment of Venous Thromboembolism  Journal Articles
• Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation  Journal Articles
• Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis  Journal Articles
• Distal deep vein thrombosis – a benign disease?  Journal Articles
• Do Heparins Do More than Just Treat Thrombosis? The Influence of Heparins on Cancer Spread  Journal Articles
• Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin–sodium) in pediatric patients  Journal Articles
• Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric patients with thromboembolic events  Journal Articles
• Dosing Frequency of Unfractionated Heparin Thromboprophylaxis  Journal Articles
• ESSENCE trial results: breaking new ground. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events.  Journal Articles
• Early Recovery and Functional Outcome are Related with Causal Stroke Subtype: Data from the Tinzaparin in Acute Ischemic Stroke Trial  Journal Articles
• Economic Evaluation of Outpatient Treatment With Low-Molecular-Weight Heparin for Proximal Vein Thrombosis  Journal Articles
• Economic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review  Journal Articles
• Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism  Journal Articles
• Effect of Nonspecific Binding to Plasma Proteins on the Antithrombin Activities of Unfractionated Heparin, Low-Molecular-Weight Heparin, and Dermatan Sulfate  Journal Articles
• Effect of covalent antithrombin-heparin on activated protein C inactivation by protein C inhibitor  Journal Articles
• Effect of substrate and fibrin polymerization inhibitor on determination of plasma thrombin generation in vitro  Journal Articles
• Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography  Journal Articles
• Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation  Journal Articles
• Effects of Unfractionated Heparin, Dermatan Sulfate and Low Molecular Weight Heparin on Vessel Wall Permeability in Rabbitsa  Journal Articles
• Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty  Journal Articles
• Efficacy and Safety of Anti-Xa-Guided Versus Fixed Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism in Trauma Patients  Journal Articles
• Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients  Journal Articles
• Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19  Journal Articles
• Efficacy of a postoperative regimen of enoxaparin in deep vein thrombosis prophylaxis  Journal Articles
• Emerging anticoagulants for the treatment of venous thromboembolism  Journal Articles
• Enoxaparin in the Treatment of Deep Vein Thrombosis With or Without Pulmonary Embolism  Journal Articles
• Enoxaparin prophylaxis in elective hip surgery.  Journal Articles
• Enoxaparin, a low molecular weight heparin, inhibits platelet-dependent prothrombinase assembly and activity by factor-Xa neutralization.  Journal Articles
• Evaluating compliance of extended venous thromboembolism prophylaxis following abdominopelvic surgery for cancer: A multidisciplinary quality improvement project  Journal Articles
• Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol  Journal Articles
• Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis  Journal Articles
• Evaluation of the Use of Low-Molecular-Weight Heparin in Neonates  Journal Articles
• Evidence for the Needs of Out-of-Hospital Thrombosis Prophylaxis  Journal Articles
• Ex-Vivo and In-Vitro Evidence that Low Molecular Weight Heparins Exhibit Less Binding to Plasma Proteins than Unfractionated Heparin  Journal Articles
• Exercise-Induced Deep Vein Thrombosis of the Upper Extremity  Journal Articles
• Extended Venous Thromboembolism Prophylaxis after Abdominopelvic Cancer Surgery: A Retrospective Review  Journal Articles
• Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy?  Journal Articles
• Extended perioperative thromboprophylaxis in patients with cancer  Journal Articles
• Extended perioperative thromboprophylaxis in patients with cancer. A systematic review.  Journal Articles
• Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery – the SAVE-HIP3 study  Journal Articles
• FEASIBILITY AND SAFETY OF FULL DOSE ANTICOAGULATION THERAPY (ACT) IN CHILDREN TREATED ACCORDING TO DANA-FARBER CANCER INSTITUTE (DFCI) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CONSORTIUM THERAPY PROTOCOLS  Conferences
• Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism  Journal Articles
• Feasibility and safety of delivering full‐dose anticoagulation therapy in children treated according to Dana‐Farber Cancer Institute acute lymphoblastic leukemia consortium therapy protocols  Journal Articles
• Fish Oils and Low-Molecular-Weight Heparin for the Reduction of Restenosis After Percutaneous Transluminal Coronary Angioplasty  Journal Articles
• Fondaparinux in the management of patients with ST-elevation acute myocardial infarction  Journal Articles
• From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes The Global Registry of Acute Coronary Events (GRACE)  Journal Articles
• From unfractionated heparins to low molecular weight heparins.  Journal Articles
• Fundamental Research in Oncology and Thrombosis 2 (FRONTLINE 2): A Follow-Up Survey  Journal Articles
• Glycosaminoglycans Bind Factor Xa in a Ca²⁺-Dependent Fashion and Modulate Its Catalytic Activity  Journal Articles
• Guide to Anticoagulant Therapy: Heparin  Journal Articles
• Guide to Anticoagulant Therapy: Heparin  Journal Articles
• Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.  Journal Articles
• Hemorrhagic Complications of Anticoagulant Treatment  Journal Articles
• Hemorrhagic Complications of Anticoagulant Treatment  Journal Articles
• Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment  Journal Articles
• Heparin Thromboprophylaxis in Medical-Surgical Critically Ill Patients  Journal Articles
• Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss  Journal Articles
• Heparin and Angiogenesis  Journal Articles
• Heparin and Low Molecular Weight Heparins Inhibit Prothrombinase Formation but not its Activity in Plasma  Journal Articles
• Heparin and Low-Molecular-Weight Heparin  Journal Articles
• Heparin and Low-Molecular-Weight Heparin  Journal Articles
• Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety  Journal Articles
• Heparin and Platelets  Journal Articles
• Heparin and low molecular weight heparins as scaffolds for assembling antithrombin and serine proteases  Journal Articles
• Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.  Journal Articles
• Heparin compromises streptokinase-induced arterial patency in rabbits  Journal Articles
• Heparin sensitivity and resistance in the neonate: An explanation  Journal Articles
• Heparin, Low Molecular Weight Heparin, and Heparin-Induced Thrombocytopenia in the ICU  Journal Articles
• Heparin-Induced Thrombocytopenia  Journal Articles
• Heparin-Induced Thrombocytopenia  Journal Articles
• Heparin-Induced Thrombocytopenia: Real-World Issues  Journal Articles
• Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention  Journal Articles
• Heparin-induced thrombocytopenia and its treatment.  Conferences
• Heparin-induced thrombocytopenia: A stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings  Journal Articles
• Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety  Journal Articles
• Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.  Journal Articles
• Heparins in sepsis-induced disseminated intravascular coagulation: Low weight—high impact?*  Journal Articles
• High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patients  Journal Articles
• Hirudin and thrombosis prophylaxis  Journal Articles
• Home-treatment of deep vein thrombosis in patients with cancer.  Journal Articles
• How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy  Journal Articles
• How Long to Treat Acute Venous Thrombosis in Cancer: Can Treatment Be Personalized?  Journal Articles
• How long is long enough for pharmacological thromboprophylaxis in urology?  Journal Articles
• How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice  Journal Articles
• ISTH guidelines for antithrombotic treatment in COVID‐19  Journal Articles
• Impact of the patient population on the risk for heparin-induced thrombocytopenia  Journal Articles
• Improving the adoption of optimal venous thromboembolism prophylaxis in critically ill patients: A process evaluation of a complex quality improvement initiative  Journal Articles
• In high-risk patients with cancer, thromboprophylaxis with rivaroxaban did not reduce VTE events at 180 days  Journal Articles
• In vitro and ex vivo Activities of CY216: Comparison with Other Low Molecular Weight Heparins  Journal Articles
• Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: A retrospective study  Conferences
• Incidence of intracranial bleeding in anticoagulated patients with minor head injury: a systematic review and meta‐analysis of prospective studies  Journal Articles
• Induction of the Acute-Phase Reaction Increases Heparin-Binding Proteins in Plasma  Journal Articles
• Inhibition of plasmin generation in plasma by heparin, low molecular weight heparin, and a covalent antithrombin–heparin complex  Journal Articles
• Initial treatment of venous thromboembolism  Journal Articles
• Interaction of low molecular weight heparin with ketorolac  Journal Articles
• International Committee Communications. Standardization and clinical use of LMW heparin. Report of the ICTH Heparin Subcommittee, Brussels, July 1987.  Journal Articles
• Investigations of the effectiveness of heparin variants as inhibitors of histones  Journal Articles
• Is Impaired Renal Function a Contraindication to the Use of Low-Molecular-Weight Heparin?  Journal Articles
• LMW Heparin for Deep Vein Thrombosis  Journal Articles
• Laboratory monitoring of low‐molecular‐weight heparin therapy  Journal Articles
• Limitations of conventional treatment options for heparin-induced thrombocytopenia.  Journal Articles
• Localization of heparin and low-molecular-weight heparin in the rat kidney  Journal Articles
• Long-Term Prophylaxis in Venous Thromboembolism: LMWH or Oral Anticoagulation?  Conferences
• Long‐duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy  Journal Articles
• Low Molecular Weight Heparin  Journal Articles
• Low Molecular Weight Heparin Administered once versus twice Daily in Patients with Venous Thromboembolism  Journal Articles
• Low Molecular Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results  Journal Articles
• Low Molecular Weight Heparins (LMWH) in the Treatment of Patients with Acute Venous Thromboembolism  Conferences
• Low molecular weight heparin  Journal Articles
• Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.  Journal Articles
• Low molecular weight heparin and bleeding in patients with chronic renal failure  Journal Articles
• Low molecular weight heparin and unfractionated heparin in the early pharmacologic management of acute coronary syndromes: a meta-analysis of randomized clinical trials.  Journal Articles
• Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels  Journal Articles
• Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial  Journal Articles
• Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer  Journal Articles
• Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer  Journal Articles
• Low molecular weight heparin: a critical analysis of clinical trials.  Journal Articles
• Low molecular weight heparin: laboratory properties and clinical evaluation. A review.  Journal Articles
• Low molecular weight heparins  Journal Articles
• Low molecular weight heparins and heparinoids  Journal Articles
• Low molecular weight heparins in the treatment of unstable angina.  Journal Articles
• Low molecular weight heparins: deep vein thrombosis prophylaxis in elective hip surgery and thrombotic stroke.  Journal Articles
• Low-Molecular-Weight Heparin  Journal Articles
• Low-Molecular-Weight Heparin Compared with Intravenous Unfractionated Heparin for Treatment of Pulmonary Embolism  Journal Articles
• Low-Molecular-Weight Heparin and Cancer Survival: Review of the Literature and Pooled Analysis of 1,726 Patients Treated for at Least Three Months  Journal Articles
• Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin  Journal Articles
• Low-Molecular-Weight Heparin as an Adjunct to Thrombolysis in ST Elevation Myocardial Infarction  Journal Articles
• Low-Molecular-Weight Heparin for Pulmonary Embolism  Journal Articles
• Low-Molecular-Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results  Journal Articles
• Low-Molecular-Weight Heparin in Pediatric Patients  Journal Articles
• Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism  Journal Articles
• Low-Molecular-Weight Heparin or Oral Anticoagulation for Secondary Prevention of Deep Vein Thrombosis in Cancer Patients  Journal Articles
• Low-Molecular-Weight Heparin versus Unfractionated Heparin for Unstable Coronary Disease  Journal Articles
• Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial  Journal Articles
• Low-Molecular-Weight Heparin vs. Warfarin for Prophylaxis against Deep-Vein Thrombosis  Journal Articles
• Low-Molecular-Weight Heparin: From the Bench to the Orthopedic Patient  Journal Articles
• Low-Molecular-Weight Heparins  Journal Articles
• Low-Molecular-Weight Heparins and Unstable Angina – Current Perspectives  Journal Articles
• Low-Molecular-Weight Heparins in Acute Unstable Coronary Artery Disease – An Update  Journal Articles
• Low-Molecular-Weight Heparins in the Treatment of Acute Coronary Syndromes  Journal Articles
• Low-Molecular-Weight and Unfractionated Heparin for Prevention of Venous Thromboembolism in Neurosurgery  Journal Articles
• Low-molecular-weight Heparin for the treatment of venous thrombosis in patients with adenocarcinoma  Journal Articles
• Low-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM)  Journal Articles
• Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants  Journal Articles
• Low-molecular-weight heparin for the treatment of venous thromboembolism  Conferences
• Low-molecular-weight heparin for the treatment of venous thromboembolism.  Journal Articles
• Low-molecular-weight heparin in patients with chronic renal insufficiency  Journal Articles
• Low-molecular-weight heparin in the treatment of pulmonary embolism.  Journal Articles
• Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: A systematic review  Journal Articles
• Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial  Journal Articles
• Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis  Journal Articles
• Low-molecular-weight heparin: from the bench to the orthopedic patient.  Journal Articles
• Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis  Journal Articles
• Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review  Journal Articles
• Low-molecular-weight heparins for the treatment of acute coronary syndrome and venous thromboembolism in patients with chronic renal insufficiency  Journal Articles
• Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.  Journal Articles
• Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trial  Conferences
• Low‐molecular‐weight heparins and heparinoids  Journal Articles
• Malignancy-associated venous thrombosis with concurrent warfarin-induced skin necrosis, venous limb gangrene and thrombotic microangiopathy  Journal Articles
• Management Of Venous Thromboembolism: Optimization By Clinical Trials  Journal Articles
• Management of Deep Vein Thrombosis and Pulmonary Embolism  Journal Articles
• Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B.  Journal Articles
• Management of iliofemoral thrombosis in a pregnant patient with heparin resistance  Journal Articles
• Management of thromboembolic disease in cancer patients.  Journal Articles
• Management of unstable angina and myocardial infarction  Journal Articles
• Management of venous thromboembolism in cancer patients.  Journal Articles
• Management strategies in unstable coronary artery disease—Current problems and future directions  Journal Articles
• Managing oral anticoagulant therapy in patients with mechanical heart valves undergoing elective surgery  Journal Articles
• Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancer  Journal Articles
• Measuring the anticoagulant effect of low molecular weight heparins in the critically ill.  Journal Articles
• Mechanism of Action and Pharmacology of Unfractionated Heparin  Journal Articles
• Mechanisms responsible for the failure of protamine 
to inactivate low‐molecular‐weight heparin  Journal Articles
• Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients  Journal Articles
• Minimizing costs for treating deep vein thrombosis: the role for fondaparinux  Journal Articles
• Monitoring Unfractionated Heparin (UFH) therapy: Which Anti Factor Xa assay is appropriate?  Journal Articles
• Mortality benefits of thromboprophylaxis  Journal Articles
• Neutralization of Enoxaparine-lnduced Bleeding by Protamine Sulfate  Journal Articles
• New Anticoagulant Strategies  Journal Articles
• New Antithrombotic Drugs: Potential for Use in Oncology  Journal Articles
• New Frontiers in the Management of Unstable Coronary Artery Disease  Journal Articles
• New advances in the management of acute coronary syndromes: 4. Low-molecular-weight heparins.  Journal Articles
• New anticoagulants: beyond heparin, low‐molecular‐weight heparin and warfarin  Journal Articles
• Newer Anticoagulants in Critically Ill Patients  Journal Articles
• Nonbleeding complications of unfractionated and low-molecular weight heparins.  Journal Articles
• Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia  Journal Articles
• Non–injection‐site necrotic skin lesions complicating postoperative heparin thromboprophylaxis  Journal Articles
• Novel anticoagulant agents: introduction  Journal Articles
• Optimal Anticoagulation for Pregnant Women with Mechanical Heart Valves  Journal Articles
• Optimal timing of starting thromboprophylaxis for patients with acute spinal cord injury: A survey of Canadian spine surgeons  Journal Articles
• Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis  Journal Articles
• Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours  Journal Articles
• Overview of low molecular weight heparins and heparinoids: basic and clinical aspects.  Journal Articles
• PREVENTION OF VENOUS THROMBO‐EMBOLISM  Journal Articles
• PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patients  Journal Articles
• PRE‐OPERATIVE FACTOR Xa–TFPI AND POST‐OPERATIVE VENOUS THROMBOSIS  Journal Articles
• PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma  Journal Articles
• Parenteral Anticoagulants  Journal Articles
• Parenteral Anticoagulants  Journal Articles
• Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation  Journal Articles
• Parenteral anticoagulation in ambulatory patients with cancer  Journal Articles
• Parenteral anticoagulation in ambulatory patients with cancer  Journal Articles
• Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review  Journal Articles
• Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines  Journal Articles
• Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation  Journal Articles
• Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry)  Journal Articles
• Perioperative Management of Oral Anticoagulation  Journal Articles
• Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants  Journal Articles
• Perioperative Management of Warfarin Therapy: To Bridge or Not to Bridge, That Is the Question  Journal Articles
• Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey.  Journal Articles
• Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians  Journal Articles
• Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation  Journal Articles
• Periprocedural Management of Oral Anticoagulation  Journal Articles
• Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy  Journal Articles
• Pharmacokinetic Profile of a Low-Molecular Weight Heparin (Reviparin) in Pregnant Patients  Conferences
• Pharmacologic tools to reduce bleeding in surgery.  Journal Articles
• Pharmacological thromboprophylaxis to prevent venous thromboembolism in patients with temporary lower limb immobilization after injury: systematic review and network meta‐analysis  Journal Articles
• Pharmacology of the low-molecular-weight heparins  Journal Articles
• Pharmacotherapy for Venous Thromboprophylaxis following Total Hip or Knee Arthroplasty: A Systematic Review and Network Meta-analysis  Journal Articles
• Plasma Thrombin Neutralization Assay: Pharmacokinetic Applications  Journal Articles
• Polish guidelines for the prevention and treatment of venous thromboembolism 2009 update  Journal Articles
• Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment?  Journal Articles
• Postoperative Low‐Molecular‐Weight Heparin Bridging Is Associated with an Increase in Wound Hematoma Following Surgery for Pacemakers and Implantable Defibrillators  Journal Articles
• Preclinical differentiation of low molecular weight heparins.  Journal Articles
• Pregnancy-Associated Venous Thromboembolism: Prevention and Treatment  Journal Articles
• Preoperative Enoxaparin Versus Postoperative Semuloparin Thromboprophylaxis in Major Abdominal Surgery  Journal Articles
• Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE  Journal Articles
• Preventing thrombophilia-related complications of pregnancy: an update  Journal Articles
• Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey  Journal Articles
• Prevention and treatment of venous thromboembolism in the elderly patient.  Journal Articles
• Prevention of Deep Vein Thrombosis after Elective Hip Surgery  Journal Articles
• Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Journal Articles
• Prevention of Venous Thromboembolism Among Hospitalized Medical Patients  Journal Articles
• Prevention of Venous Thrombosis After Elective Hip Surgery  Journal Articles
• Prevention of the Postthrombotic Syndrome with Anticoagulation: A Narrative Review  Journal Articles
• Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents  Journal Articles
• Prevention of venous thromboembolism after surgery: A review of enoxaparin  Journal Articles
• Prevention of venous thromboembolism in critically ill surgery patients: A cross-sectional study  Journal Articles
• Prise en charge d’une surdose intentionnelle d’héparine de bas poids moléculaire  Journal Articles
• Prolonged Antithrombin Activity of Low-Molecular-Weight Heparins  Journal Articles
• Prophylactic doses of enoxaparin and heparin inhibit prothrombin activation.  Journal Articles
• Prophylactically Effective Doses of Enoxaparin and Heparin Inhibit Prothrombin Activation  Journal Articles
• Prophylactically equivalent doses of Enoxaparin and unfractionated heparin inhibit in vivo coagulation to the same extent  Journal Articles
• Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study  Journal Articles
• Prophylaxis of Venous Thromboembolism in Stroke Patients  Journal Articles
• Präoperative Bewertung des Blutungs- und Thromboseembolierisikos  Journal Articles
• Pulmonary Embolism in Pregnancy  Journal Articles
• Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism  Journal Articles
• Randomized Trial of Warfarin Nomograms  Journal Articles
• Randomized Trial of Warfarin Nomograms  Journal Articles
• Randomized trial of warfarin nomograms.  Journal Articles
• Rationale for development of low-molecular-weight heparins and their clinical potential in the prevention of postoperative venous thrombosis  Conferences
• Recent clinical trials in the treatment of venous thromboembolism and unstable angina with low molecular weight heparins  Journal Articles
• Recommendations on biosimilar low‐molecular‐weight heparins  Journal Articles
• Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis  Journal Articles
• Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: A randomized trial  Journal Articles
• Reduction of Out-of-Hospital Symptomatic Venous Thromboembolism by Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Elective Hip Arthroplasty  Journal Articles
• Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia  Journal Articles
• Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic management  Journal Articles
• Reviparin in Acute Myocardial Infarction—Reply  Journal Articles
• Reviparin in acute myocardial infarction.  Journal Articles
• Risk factors for MACE and bleeding in atrial fibrillation patients undergoing surgery: Insights from the bridge trial  Journal Articles
• Risk of bleeding with vitamin K antagonists compared with low-molecular-weight heparin after orthopedic surgery: a rebuttal  Journal Articles
• Rivaroxaban and apixaban are less effective than enoxaparin for the prevention of catheter-induced clotting in vitro  Journal Articles
• Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study  Journal Articles
• Routine heparin for patients with cancer? One answer, more questions  Journal Articles
• Routine home treatment of deep vein thrombosis  Journal Articles
• Routine home treatment of deep vein thrombosis - Is now a reality  Journal Articles
• Safety and Efficacy of Low Molecular Weight Heparins for Hemodialysis in Patients with End-Stage Renal Failure  Journal Articles
• Safety of dalteparin for the prophylaxis of venous thromboembolism in elderly medical patients with renal insufficiency: a pilot study.  Journal Articles
• Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence  Journal Articles
• Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer  Journal Articles
• Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE‐HIP1, SAVE‐HIP2 and SAVE‐KNEE  Journal Articles
• Should vitamin K antagonist therapy be started simultaneously with parenteral anticoagulation  Journal Articles
• Significant association with location of central venous line placement and risk of venous thrombosis in children  Journal Articles
• Significant variation in mortality and functional outcome after acute ischaemic stroke between western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST)  Journal Articles
• So, Does Low-Molecular-Weight Heparin Cause Less Heparin-Induced Thrombocytopenia Than Unfractionated Heparin or Not?  Journal Articles
• Standard and Low Molecular Weight Heparin Have no Effect on Tissue Plasminogen Activator Induced Plasma Clot Lysis or Fibrinogenolysis  Journal Articles
• Standardization and Clinical Use of LMW Heparin  Journal Articles
• State of the Art-A Journey through the World of Antithrombotic Therapy  Journal Articles
• Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves  Journal Articles
• Stroke severity, early recovery and outcome are each related with clinical classification of stroke: Data from the ‘Tinzaparin in Acute Ischaemic Stroke Trial’ (TAIST)  Journal Articles
• Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective  Journal Articles
• Suboptimal Monitoring and Dosing of Unfractionated Heparin in Comparative Studies with Low-Molecular-Weight Heparin  Journal Articles
• Successors to heparin: new antithrombotic agents.  Journal Articles
• Survey of pharmacologic thromboprophylaxis in critically ill children*  Journal Articles
• THE EFFECTS OF DNASE I AND LOW-MOLECULAR-WEIGHT HEPARIN IN A MURINE MODEL OF POLYMICROBIAL ABDOMINAL SEPSIS  Journal Articles
• The Additive Effect of Low Molecular Weight Heparins on Thrombin Inhibition by Dermatan Sulfate  Journal Articles
• The Binding of Unfractionated Heparin and Low Molecular Weight Heparin to Thrombin-Activated Human Endothelial Cells  Journal Articles
• The Cost-Effectiveness of Extended-Duration Antithrombotic Prophylaxis After Total Hip Arthroplasty  Journal Articles
• The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism  Journal Articles
• The Effects of Standard and Low Molecular Weight Heparin on Bone Nodule Formation In Vitro  Journal Articles
• The Efficacy and Safety of Heparin in Patients With Sepsis  Journal Articles
• The Khorana score for the prediction of venous thromboembolism in patients with solid cancer: an individual patient data meta-analysis  Conferences
• The Perioperative Management of Antithrombotic Therapy  Journal Articles
• The Relationship between Anti-Factor Xa Level and Clinical Outcome in Patients Receiving Enoxaparine Low Molecular Weight Heparin to Prevent Deep Vein Thrombosis after Hip Replacement  Journal Articles
• The challenges and lessons learned in conducting clinical trials in pregnant women with antiphospholipid syndrome  Journal Articles
• The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: An evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients  Journal Articles
• The comparison of the pharmacokinetics of a low molecular weight heparin in the newborn and adult pig  Journal Articles
• The emerging role of low-molecular-weight heparin in cardiovascular medicine  Journal Articles
• The low molecular weight heparin Enoxaparin inhibits the consumption of factor VII and prothrombin activation in vivo associated with elective knee replacement surgery  Journal Articles
• The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians  Journal Articles
• The new heparins  Journal Articles
• The relationship between ex vivo anti-factor Xa levels and efficacy/safety of low molecular weight heparin.  Journal Articles
• The risk and prevention of venous thromboembolism in the pregnant traveller  Journal Articles
• The safety of antithrombotic therapy during pregnancy  Journal Articles
• The safety of co-administered continuous epidural analgesia and low-molecular-weight heparin after major orthopedic surgery: Assessment of a standardized patient management protocol  Journal Articles
• The status of new anticoagulants  Journal Articles
• The uses of heparin to treat burn injury.  Journal Articles
• Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19  Journal Articles
• Therapy of unstable angina with the low molecular weight heparins  Journal Articles
• Think of HIT When Thrombosis Follows Heparin  Journal Articles
• Thrombocytopenia in Critically Ill Patients Receiving Thromboprophylaxis  Journal Articles
• Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art  Journal Articles
• Thromboembolism in children with sarcoma  Journal Articles
• Thromboembolism prevention in ischaemic stroke  Journal Articles
• Thrombolysis and Adjunctive Therapy in Acute Myocardial Infarction  Conferences
• Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis  Journal Articles
• Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial  Journal Articles
• Thromboprophylaxie hospitalière : doit-on adapter la dose d’énoxaparine au poids des patients ?  Journal Articles
• Thromboprophylaxis after Knee Arthroscopy  Journal Articles
• Thromboprophylaxis after knee arthroscopy does not decrease the risk of deep vein thrombosis: a network meta-analysis  Journal Articles
• Thromboprophylaxis in Medical Patients – Why Not For All?  Conferences
• Thromboprophylaxis in Patients Receiving Chemotherapy  Journal Articles
• Thromboprophylaxis in Patients with Acute Spinal Cord Injury: A Narrative Review  Journal Articles
• Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin  Journal Articles
• Thromboprophylaxis in medical–surgical critically ill patients  Journal Articles
• Thromboprophylaxis in surgical patients.  Journal Articles
• Thromboprophylaxis in the intensive care unit: Focus on medical–surgical patients  Journal Articles
• Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit  Journal Articles
• Thromboprophylaxis practice patterns in two Western Australian teaching hospitals.  Journal Articles
• Thrombosis and cancer: implications beyond Trousseau  Journal Articles
• Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial  Journal Articles
• To anticoagulate? Controversy in the management of thrombotic complications of head & neck infections  Journal Articles
• Treatment and outcomes after on-treatment recurrent venous thromboembolism in patients with cancer: a post hoc analysis of the Hokusai venous thromboembolism cancer study.  Journal Articles
• Treatment and prophylaxis of venous thromboembolism during pregnancy  Journal Articles
• Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis  Journal Articles
• Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction  Journal Articles
• Treatment of Thrombotic Disorders in Cancer Patients  Journal Articles
• Treatment of Venous Thromboembolism in Cancer Patients  Journal Articles
• Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management  Journal Articles
• Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis  Journal Articles
• Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective  Journal Articles
• Tumorkrankheit, Thromboembolien und antithrombotische Therapie: Gibt es ein Antikoagulans der Wahl?  Journal Articles
• Unanswered questions in venous thromboembolism  Journal Articles
• Uncomplicated outpatient deep venous thrombosis management with a novel care pathway: Is it ready for prime time?  Journal Articles
• Unfractionated and Low-Molecular-Weight Heparin as Adjuncts to Thrombolysis in Aspirin-Treated Patients With ST-Elevation Acute Myocardial Infarction  Journal Articles
• Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis  Journal Articles
• Unfractionated versus Low-Molecular-Weight Heparin for Deep Venous Thrombosis  Journal Articles
• Unstable angina.  Journal Articles
• Unstable angina.  Journal Articles
• Updates in thrombosis in pediatrics: where are we after 20 years?  Journal Articles
• Urologic Surgery  Journal Articles
• Use of Antithrombotic Agents During Pregnancy  Journal Articles
• Use of Antithrombotic Agents During Pregnancy  Journal Articles
• Use of Heparins in Non-ST-Elevation Acute Coronary Syndromes  Journal Articles
• Use of Low Molecular Weight Heparins in Patients with Renal Failure; Time to Re-evaluate Our Preconceptions  Journal Articles
• Use of a single anti-Xa calibration curve is adequate for monitoring enoxaparin and tinzaparin levels in children  Journal Articles
• Use of antithrombotic agents during pregnancy.  Journal Articles
• Using low molecular weight heparin in special patient populations  Journal Articles
• VTE Prophylaxis in Critically Ill Adults  Journal Articles
• VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy  Journal Articles
• Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014  Journal Articles
• Venous Thromboembolism in Hip Fracture Patients: A Subanalysis of the FAITH and HEALTH Trials  Journal Articles
• Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy  Journal Articles
• Venous thromboembolism in critical illness in a community intensive care unit  Journal Articles
• Venous thromboembolism in pregnancy: diagnosis, management and prevention  Journal Articles
• Venous thromboembolism: diagnosis and management of deep venous thrombosis  Journal Articles
• Venous thromboembolism: diagnosis and management of pulmonary embolism  Journal Articles
• Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism  Journal Articles
• Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K  Journal Articles
• Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more  Journal Articles
• What is the role for antithrombotics in cancer care?  Journal Articles
• Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada?  Journal Articles
• Women’s values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview study  Journal Articles
• Women’s values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review  Journal Articles
• Work‐related effort thrombosis in a millwright: A case report  Journal Articles
• [Congestive cardiomyopathy and left intraventricular thrombus as a manifestation of Churg-Strauss syndrome].  Journal Articles
• [Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer].  Journal Articles
• [Polish guidelines for the prevention and treatment of venous thromboembolism: 2009 update].  Journal Articles
• “Part of the Ritual”: Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome  Journal Articles